Hunterian Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $4.59M

  • Investors
  • 3

Hunterian General Information

Description

Developer of gene-editing technologies designed to cure genetic diseases by correcting deoxyribonucleic acid mutations. The company's technologies offer to use of novel genetic elements to enable in vivo delivery via a single Adeno-associated virus, enabling medical professionals to analyze genes and build therapies.

Contact Information

Website
www.hunterian.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 100 Pacific Street
  • Cambridge, MA 02139
  • United States
+1 (888)
Primary Industry
Biotechnology
Other Industries
Other Healthcare Services
Other Healthcare Technology Systems
Vertical(s)
Digital Health, HealthTech, Life Sciences
Corporate Office
  • 100 Pacific Street
  • Cambridge, MA 02139
  • United States
+1 (888)

Hunterian Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hunterian Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Seed Round 20-Sep-2023 $4.59M Completed Generating Revenue
3. Grant 10-Aug-2022 Completed Generating Revenue
2. Grant 27-May-2021 $300K Completed Generating Revenue
1. Accelerator/Incubator Completed Startup
To view Hunterian’s complete valuation and funding history, request access »

Hunterian Patents

  • 4

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 3

    Pending

  • Expiring in next 12 mo

Hunterian Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240173436-A1 Compact promoters for gene expression Pending 31-Mar-2021
US-20240175006-A1 Compact promoters for gene editing Pending 31-Mar-2021
US-20200354419-A1 Compositions and methods of use thereof for the treatment of duchenne muscular dystrophy Inactive 03-Nov-2017
US-20240116993-A1 Compositions and methods of use thereof for the treatment of duchenne muscular dystrophy Pending 03-Nov-2017 C07K14/4708

Hunterian Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hunterian Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institutes of Health Government
Cystic Fibrosis Foundation Limited Partner
Johns Hopkins Technology Ventures Accelerator/Incubator Minority
To view Hunterian’s complete investors history, request access »

Ready to get started?

Request a free trial

Hunterian FAQs

  • When was Hunterian founded?

    Hunterian was founded in 2016.

  • Where is Hunterian headquartered?

    Hunterian is headquartered in Cambridge, MA.

  • What is the size of Hunterian?

    Hunterian has 5 total employees.

  • What industry is Hunterian in?

    Hunterian’s primary industry is Biotechnology.

  • Is Hunterian a private or public company?

    Hunterian is a Private company.

  • What is Hunterian’s current revenue?

    The current revenue for Hunterian is .

  • How much funding has Hunterian raised over time?

    Hunterian has raised $4.59M.

  • Who are Hunterian’s investors?

    National Institutes of Health, Cystic Fibrosis Foundation, and Johns Hopkins Technology Ventures have invested in Hunterian.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »